Interestingly, at 24 h post-injection, this highest accumulation in Ldlr WT tumors was associated with the lowest levels in excretory organs (Fig. 4b vs Supplementary Fig. 4e), indicating highest tumor-selective targeting potential at this time-point. The gene discussed is LDLR; the disease is neoplasm.